ASA Stubs Out E-Cigarette Firm’s Smoking Cessation Claims
The UK's advertising regulator has ruled that government health statements cannot be used to support smoking cessation claims for unlicensed e-cigarettes.
You may also be interested in...
JAMA study results could spur additional research with subjects from broader pool of candidates for determining whether ENDS products have potential for approval as NRT products. Studies typically limit participants to consumers who want to quit, but expanding pool to include those not interested could add to research results more instances of successful quitting.
Warnings to five marketers don’t state smoking cessation claims and vaping also aren’t related. Rather providing nicotine replacement therapy, the products identified in the warnings were reported as being marketed with claims including “Fight off tumors and alleviate symptoms of chemotherapy."
France's EA Pharma is now operating as part of Olyos Group, alongside Spain’s Drasanvi, Italy’s Stardea and recently-acquired US dietary supplements firm W Group.